16 articles for AD Michel
The following articles (labelled with PubMed ID or TBD) are for your review
PMID
Cmpds
Data
Article Title
Organization
3
Antihypertensive 9-substituted 1-oxa-4,9-diazaspiro[5.5]undecan-3-ones.

TBA
43
2-(Quinuclidin-3-yl)pyrido[4,3-b]indol-1-ones and isoquinolin-1-ones. Potent conformationally restricted 5-HT3 receptor antagonists.

Syntex Research
51
Discovery of novel, non-acidic 1,5-biaryl pyrrole EP1 receptor antagonists.

Glaxosmithkline
32
1,5-Biaryl pyrrole derivatives as EP1 receptor antagonists: Structure-activity relationships of 4- and 5-substituted benzoic acid derivatives.

Glaxosmithkline
29
1,5-Biaryl pyrrole derivatives as EP1 receptor antagonists. Structure-activity relationships of 6-substituted and 5,6-disubstituted benzoic acid derivatives.

Glaxosmithkline
20
Identification of 2-oxo-N-(phenylmethyl)-4-imidazolidinecarboxamide antagonists of the P2X(7) receptor.

Glaxosmithkline
23
Discovery and structure-activity relationships of a series of pyroglutamic acid amide antagonists of the P2X7 receptor.

Glaxosmithkline
24
Structure-activity relationships and in vivo activity of (1H-pyrazol-4-yl)acetamide antagonists of the P2X(7) receptor.

Glaxosmithkline
32
Synthesis and structure-activity relationships of a series of (1H-pyrazol-4-yl)acetamide antagonists of the P2X7 receptor.

Glaxosmithkline
1
Identification of novel glycine sulfonamide antagonists for the EP1 receptor.

Glaxosmithkline
24
A novel series of benzimidazole NR2B-selective NMDA receptor antagonists.

Glaxosmithkline
18
Synthesis and biological activity of a series of tetrasubstituted-imidazoles as P2X(7) antagonists.

Glaxosmithkline
6
The discovery of 6-[2-(5-chloro-2-{[(2,4-difluorophenyl)methyl]oxy}phenyl)-1-cyclopenten-1-yl]-2-pyridinecarboxylic acid, GW848687X, a potent and selective prostaglandin EP1 receptor antagonist for the treatment of inflammatory pain.

Gsk
1
Structure-activity relationships of 1,5-biaryl pyrroles as EP1 receptor antagonists.

Glaxosmithkline
9
Discovery of novel biaryl heterocyclic EP1 receptor antagonists.

Glaxosmithkline
21
Discovery of {4-[4,9-bis(ethyloxy)-1-oxo-1,3-dihydro-2H-benzo[f]isoindol-2-yl]-2-fluorophenyl}acetic acid (GSK726701A), a novel EP

Glaxosmithkline